Latest Amrutanjan Health Care stock price
Amrutanjan Health Care P/E Ratio
AMRUTANJAN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
30.81
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
30.81
Current Price
₹581.10
EPS (TTM)
₹14.08
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
48.21
Sector Median
27.3
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Amrutanjan Health Care
- Stock appears overvalued with PE of 30.81, suggesting caution for new investments
- Trading at discount to sector average PE of 48.21
View the AMRUTANJAN equity price for detailed stock performance.
Related Pages for Amrutanjan Health Care
Additional stock information and data for AMRUTANJAN
Sector P/E Ratio Comparison
Comparing Amrutanjan Health Care with other companies in Healthcare sector
Sector Average
48.21
Sector Median
27.3
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |